anti cd31 (Cell Signaling Technology Inc)
Structured Review
Anti Cd31, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd31/pmc12992974-282-65-67
Average 86 stars, based on 1 article reviews
Images
Related Articles
Western Blot:Article Title: MEG3 in glioma stem cells promotes glioblastoma angiogenesis through FUBP3-mediated VGF expression. Article Snippet: Signal detection was performed using the ChemiDoc Imaging System (BIO-RAD). .. The primary antibodies used for immunoblotting included VGF (Abcam, ab313783, 1:1000 dilution), β-actin (Proteintech, 66009-1-Ig, 1:5000 dilution), FUBP3 (Proteintech, 10623-1-AP, 1:1000 dilution), OLIG2 (Abcam, ab109186, 1:1000 dilution), SOX2 (Cell Signaling Technology, 3579, 1:2000 dilution), GFAP (Biolegend, PRB-571C, 1:1000 dilution), and Staining:Article Title: PRMT5–mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth Article Snippet: .. Tumor sections were stained with antibodies against HBsAg (Creative Diagnostics, #DMABT–51328MH) and Article Title: PRMT5-mediated symmetric dimethylation of SHBs at Arg169 stabilizes SHBs and promotes angiogenesis and tumor growth. Article Snippet: .. Tumor sections were stained with antibodies against HBsAg (Creative Diagnostics, #DMABT–51328MH) and Incubation:Article Title: MEG3 in glioma stem cells promotes glioblastoma angiogenesis through FUBP3-mediated VGF expression Article Snippet: .. The sections were incubated overnight at 4°C with primary antibodies targeting VGF (Abcam, ab313783, 1:250 dilution) and Article Title: Tailored Porous Bimetallic Nanozyme Platform for Full-Cycle Therapeutics of Intestinal Ischemia/Reperfusion. Article Snippet: .. Blocking treatments were performed, and the sections were incubated overnight at 4◦C with primary antibodies against CD86 (Proteintech, 13395-1-AP, 1:200, RRID:AB_2074882), CD206 (Cell Signaling Technology, 24595S, 1:100), α-SMA (Proteintech, 14395-1-AP, 1:200, RRID:AB_2223009), Blocking Assay:Article Title: Tailored Porous Bimetallic Nanozyme Platform for Full-Cycle Therapeutics of Intestinal Ischemia/Reperfusion. Article Snippet: .. Blocking treatments were performed, and the sections were incubated overnight at 4◦C with primary antibodies against CD86 (Proteintech, 13395-1-AP, 1:200, RRID:AB_2074882), CD206 (Cell Signaling Technology, 24595S, 1:100), α-SMA (Proteintech, 14395-1-AP, 1:200, RRID:AB_2223009), |
